SLNX News Alert Solanex Management (SLNX) 0.0008 02/15/2015
Post# of 64074
Solanbridge Group Announces Meetings in Sri Lanka
ACCESSWIRE - Mon Jan 12, 7:54AM CST
Hickey to Discuss Medical Marijuana Industry with Sri Lankan Officials
Solanbridge Group Announces the addition of Grace White to Board of Solanbridge Nova Scotia
ACCESSWIRE - Sat Dec 13, 11:01PM CST
Untitled Document
Solanbridge Group Announces the Hiring of Director of Security, Keith McGuire
ACCESSWIRE - Mon Dec 08, 5:01AM CST
McGuire retired at the S/Sgt. Rank from RCMP in 2007
Solanbridge Group Announces Reseller Agreement With Vega Biofuels SLNX to market Biochar in Canada, Jamaica, and South Central
ACCESSWIRE - Thu Dec 04, 5:00AM CST
Image: http://www.accesswire.comdata:image/png;base6...lFTkSuQmCC
Vega Biofuels' "Grow With Us" Marketing Campaign Expands With Signing of International Reseller
Marketwired - Tue Dec 02, 11:27AM CST
VEGA BIOFUELS, INC. (OTC PINK: VGPR) announced today that it has entered into a Reseller Agreement with Texas based Solanbridge Group, Inc. (OTC PINK: SLNX) that allows Solanbridge Group to market Vega's Biochar product to its clients worldwide.
Solanbridge Group Inc Announces the Departure of David M. Green
ACCESSWIRE - Mon Oct 27, 6:05AM CDT
Former CEO finalizes retirement of shares
Solanbridge Group Inc Announces Addition of Wendy Coffin
PR Newswire - Tue Oct 21, 8:27AM CDT
Solanbridge Group Inc (OTC: SLNX) is pleased to announce that its subsidiary Solanbridge Group Nova Scotia, Inc., has added Ms. Wendy Coffin to its Board of Directors. She will act as the subsidiary's Medical Director.
Cannabis Stocks Move Lower After Poor Data at GW Pharma
ACCESSWIRE - Mon Oct 20, 9:33AM CDT
Whitefish, MT / ACCESSWIRE / October 20, 2014 / Cannabis stocks moved largely lower over the past week, led by a 12% drop in GW Pharmaceuticals plc (NASDAQ: GWPH). The company's Phase IIA study of GWP42003 - a CBD-based compound - for ulcerative colitis failed to meet the primary endpoint of disease remission. While second endpoints were promising, the drug also showed poor toleration among patients with a number withdrawing.
GWPH: 78.09 (+1.70)
Solanbridge Group Inc Announces Acquisition of BICOM, LLC
PR Newswire - Mon Oct 13, 10:46AM CDT
Solanbridge Group Inc (OTC: SLNX) is pleased to announce that SLNX has acquired the majority interest in BICOM, LLC, a sales and telemarketing firm. BICOM will add revenue to SLNX's gross revenue immediately.
Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com
PR Newswire - Fri Jul 25, 8:41AM CDT
Solanbridge Group Inc (OTC: SLNX) is pleased to announce that SLNX has acquired the majority interest in Buzznbrewz.com and the Letter of Intent issued on July 11, 2014 has been replaced with a fully executed Purchase Agreement.
Solanbridge Group Inc Announces Telephone Conference Call with Shareholders
PR Newswire - Thu Jun 19, 7:06AM CDT
Solanbridge Group Inc (OTC: SLNX) is pleased to announce that on Friday, June 20, 2014 at 9:00 a.m. Central time SLNX will be holding a telephone conference call with all SLNX shareholders.